ASND
Ascendis Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ASND fundamentals
Ascendis Pharma (ASND) released its earnings on Nov 12, 2025: revenue was 250.69M (YoY +288.93%), beat estimates; EPS was -1.17 (YoY +38.97%), missed estimates.
Revenue / YoY
250.69M
+288.93%
EPS / YoY
-1.17
+38.97%
Report date
Nov 12, 2025
ASND Earnings Call Summary for Q3,2025
- YORVIPATH Growth: €143.1M Q3 revenue, 4,250+ U.S. patients, 70% approval rate, Japan launch, and 30+ European markets.
- SKYTROFA Expansion: AGHD approval, €50.7M Q3 revenue, Phase III trial for additional growth disorders.
- TransCon CNP Update: FDA PDUFA date November 30, 2025; Phase II combo trial shows 3x linear growth, Phase III planned for Q4 2025.
- Financial Health: €214M total revenue, €11M operating profit, €539M cash, and 9% cash growth.
EPS
Revenue
Revenue & Expenses
ASND has released its 2025 Q3 earnings report, with revenue of 250.70M, reflecting a YoY change of 288.95%, and net profit of -71.57M, showing a YoY change of 35.26%. The Sankey diagram below clearly presents ASND's revenue sources and cost distribution.
Key Indicators
Ascendis Pharma (ASND) key financial stats and ratios, covering profitability, financial health, and leverage.
Ascendis Pharma (ASND)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ascendis Pharma (ASND)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ascendis Pharma (ASND)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ascendis Pharma (ASND) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ascendis Pharma (ASND) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Ascendis Pharma’s earnings call?Did Ascendis Pharma beat or miss consensus estimates last quarter?What were the key takeaways from Ascendis Pharma's earnings call?What is Ascendis Pharma's latest dividend and current dividend yield?What is the market's earnings forecast for Ascendis Pharma next quarter?What is Ascendis Pharma's gross profit margin?What does Ascendis Pharma do and what are its main business segments?What guidance did Ascendis Pharma's management provide for the next earnings period?
